Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Overlap Weighting: A Propensity Score Method That Mimics Attributes of a Randomized Clinical Trial.

Publication ,  Journal Article
Thomas, LE; Li, F; Pencina, MJ
Published in: JAMA
June 16, 2020

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA

DOI

EISSN

1538-3598

Publication Date

June 16, 2020

Volume

323

Issue

23

Start / End Page

2417 / 2418

Location

United States

Related Subject Headings

  • SARS-CoV-2
  • Propensity Score
  • Pneumonia, Viral
  • Pandemics
  • General & Internal Medicine
  • Coronavirus Infections
  • Coronavirus
  • COVID-19
  • Betacoronavirus
  • Angiotensin-Converting Enzyme Inhibitors
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Thomas, L. E., Li, F., & Pencina, M. J. (2020). Overlap Weighting: A Propensity Score Method That Mimics Attributes of a Randomized Clinical Trial. JAMA, 323(23), 2417–2418. https://doi.org/10.1001/jama.2020.7819
Thomas, Laine E., Fan Li, and Michael J. Pencina. “Overlap Weighting: A Propensity Score Method That Mimics Attributes of a Randomized Clinical Trial.JAMA 323, no. 23 (June 16, 2020): 2417–18. https://doi.org/10.1001/jama.2020.7819.
Thomas, Laine E., et al. “Overlap Weighting: A Propensity Score Method That Mimics Attributes of a Randomized Clinical Trial.JAMA, vol. 323, no. 23, June 2020, pp. 2417–18. Pubmed, doi:10.1001/jama.2020.7819.
Thomas LE, Li F, Pencina MJ. Overlap Weighting: A Propensity Score Method That Mimics Attributes of a Randomized Clinical Trial. JAMA. 2020 Jun 16;323(23):2417–2418.
Journal cover image

Published In

JAMA

DOI

EISSN

1538-3598

Publication Date

June 16, 2020

Volume

323

Issue

23

Start / End Page

2417 / 2418

Location

United States

Related Subject Headings

  • SARS-CoV-2
  • Propensity Score
  • Pneumonia, Viral
  • Pandemics
  • General & Internal Medicine
  • Coronavirus Infections
  • Coronavirus
  • COVID-19
  • Betacoronavirus
  • Angiotensin-Converting Enzyme Inhibitors